Latest Reports

The “2021 United States Retina Atlas” provides a geographic analysis of retinal treatment opportunity and key demographic metrics in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The Retina Atlas offers strategic insights into the top potential markets in the US by providing demographic information of selected metropolitan populations, and profiles of selected metropolitan areas and applicable retinal treatment opportunity, current estimates for retina surgery volume by metropolitan area, current estimates for retina surgeons by metropolitan area, and comprehensive directory of US ophthalmic practices performing retinal IVTs and vitrectomies.

The first-edition “2020 Ophthalmic Landscape Report” offers a high-level analysis of the 2020 global ophthalmic market by region and specialty and forecasts market performance over the next five years. It discusses important trends and key factors for future success.

The “2021 US Cataract Pharmaceuticals Market Report” offers an in-depth examination of the current cataract pharmaceuticals market in the United States and forecasts market performance over the next five years. The report includes analysis of current markets, identification of important trends, and discussion of key factors for future success.

Market Scope has been meticulously tracking the effects of COVID-19 on the ophthalmic industry since the onset. After surveying US practices throughout 2020, we recently began surveying in Europe to better understand the impact on patient backlog, surgical procedures, adoption of technology, patient selection, and much more more. Our "2021 European COVID-19 Ophthalmic Practice Impact Survey Report" summarizes those findings for industry and surgeons to gain valuable insight into the markets' recovery.

The “2020 Ophthalmic Deals Book” analyzes investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

The report covers investments in ophthalmic ventures in 2020, with comparisons to 2018 and 2019, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.

Market Scope surveyed 105 ophthalmologists and orthopedic surgeons on March 24, 2020, to measure the impact of COVID-19 on their surgical practices and perceptions on how long the effects of the pandemic would impact their practice. The results of this survey are included in this report, which is being offered free of charge as a courtesy to our clients.

Since 2001, Market Scope has conducted annual surveys of US refractive surgeons on important issues regarding practice characteristics, product preferences, surgical techniques, and practice marketing. Our survey highlights practice patterns regarding laser vision correction and refractive lens exchange. We also ask refractive surgeons to rate manufacturers in the industry and their products and services. Leading ophthalmic firms and organizations sponsor the survey in order to better understand industry dynamics and gain important insights into surgeons’ experiences and preferences, as well as emerging trends. 

Our survey is designed to improve decision-making process by providing clients with the most accurate assessment of the market and its future directions. Our approach includes trend analysis based on comparisons with information gathered in previous years. All information is presented in color charts and tables with concise narratives for enhanced clarity and context.